Homozygous deletion of the survival motor neuron 2 gene is a prognostic factor in sporadic ALS

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Neurology

• Publication date

  2001-03-27

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1212/WNL.56.6.749PMID 11274309
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Immunolocalization of NAIP in the human brain and spinal cord

  2000cited by this paper
• SMA carrier testing – validation of hemizygous SMN exon 7 deletion test for the identification of proximal spinal muscular atrophy carriers and patients with a single allele deletion

  2000cited by this paper
• Deletions causing spinal muscular atrophy do not predispose to amyotrophic lateral sclerosis.

  1999cited by this paper
• Duplications and de novo deletions of the SMNt gene demonstrated by fluorescence-based carrier testing for spinal muscular atrophy.

  1999cited by this paper
• The role of the SMN gene in proximal spinal muscular atrophy.

  1998cited by this paper
• Association between centromeric deletions of the SMN gene and sporadic adult‐onset lower motor neuron disease

  1998cited by this paper
• Correlation of SMNt and SMNc gene copy number with age of onset and survival in spinal muscular atrophy

  1998cited by this paper
• What's in a name? Amyotrophic lateral sclerosis, motor neuron disease, and allelic heterogeneity

  1998cited by this paper
• Differential SMN2 expression associated with SMA severity

  1998cited by this paper
• When is a deletion not a deletion? When it is converted.

  1997cited by this paper
• The relationship of spinal muscular atrophy to motor neuron disease: investigation of SMN and NAIP gene deletions in sporadic and familial ALS.

  1997cited by this paper
• Genomic variation and gene conversion in spinal muscular atrophy: implications for disease process and clinical phenotype.

  1997cited by this paper
• Cloning, characterization, and copy number of the murine survival motor neuron gene: homolog of the spinal muscular atrophy-determining gene.

  1997cited by this paper
• Identification of proximal spinal muscular atrophy carriers and patients by analysis of SMNT and SMNC gene copy number.

  1997cited by this paper
• Apparent gene conversions involving the SMN gene in the region of the spinal muscular atrophy locus on chromosome 5.

  1996cited by this paper
• Hybrid survival motor neuron genes in patients with autosomal recessive spinal muscular atrophy: new insights into molecular mechanisms responsible for the disease.

  1996cited by this paper
• Analysis of chromosome 5q13 genes in amyotrophic lateral sclerosis: Homozygous naip deletion in a sporadic case

  1996cited by this paper
• Identification and characterization of a spinal muscular atrophy-determining gene

  1995cited by this paper
• Natural history of amyotrophic lateral sclerosis in a database population. Validation of a scoring system and a model for survival prediction.

  1995cited by this paper
• PCR-based DNA test to confirm clinical diagnosis of autosomal recessive spinal muscular atrophy.

  1995cited by this paper
• Deletions of the survival motor neuron gene in unaffected siblings of patients with spinal muscular atrophy.

  1995cited by this paper
• Motor Neuron Disease: The Clinical Syndrome

  1995cited by this paper
• El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial "Clinical limits of amyotrophic

  1994cited by this paper
• El escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis

  1994cited by this paper
• Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis.

  1993cited by this paper
• Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis

  1993cited by this paper
• A survival analysis of 155 cases of progressive muscular atrophy

  1985cited by this paper
• The central nervous system in motor neurone disease

  1970cited by this paper

• A variant of the Hspa8 synaptic chaperone modifies disease in a SOD1G86R mouse model of amyotrophic lateral sclerosis.

  2024cites this paper
• Beyond C9orf72: repeat expansions and copy number variations as risk factors of amyotrophic lateral sclerosis across various populations

  2024influential citation
• The Spectrum of Childhood-Onset Lower Motor Neuron Disease of Spinal Muscular Atrophy Phenotype Associated with Survival Motor Neuron-2 Gene Deletion

  2023cites this paper
• Real-Time PCR-Based Screening for Homozygous SMN2 Deletion Using Residual Dried Blood Spots

  2023cites this paper
• Analysis of Structural Variants Previously Associated With ALS in Europeans Highlights Genomic Architectural Differences in Africans

  2023cites this paper
• Genetic factors for survival in amyotrophic lateral sclerosis: an integrated approach combining a systematic review, pairwise and network meta-analysis

  2022cites this paper
• The Effect of SMN Gene Dosage on ALS Risk and Disease Severity

  2021cites this paper
• Elderly patient with 5q spinal muscular atrophy type 4 markedly improved by Nusinersen.

  2020cites this paper
• Looking for the Missing Link: Application of Copper Isotope Metallomics to Amyotrophic Lateral Sclerosis

  2018cites this paper
• copy number as a modifying factor of survival in Serbian patients with sporadic amyotrophic lateral sclerosis

  2018cites this paper
• Prevalence, incidence and carrier frequency of 5q–linked spinal muscular atrophy – a literature review

  2017cites this paper
• Copy Number Variations in Amyotrophic Lateral Sclerosis: Piecing the Mosaic Tiles Together through a Systems Biology Approach

  2017cites this paper
• Genetics of amyotrophic lateral sclerosis.

  2017cites this paper
• Effekte pharmakologischer Interventionen auf Muskelatrophie im Mausmodell der amyotrophen Lateralsklerose (ALS)

  2017cites this paper
• HLA-DRA/HLA-DRB5 polymorphism affects risk of sporadic ALS and survival in a southwest Chinese cohort.

  2017cites this paper
• A rapid functional decline type of amyotrophic lateral sclerosis is linked to low expression of TTN

  2016cites this paper
• Elucidating the effect of aggregated SOD1 on microglia and astrocytes in ALS

  2016cites this paper
• Copy Number Variations in the Survival Motor Neuron Genes: Implications for Spinal Muscular Atrophy and Other Neurodegenerative Diseases

  2016cites this paper
• Étude LENSLA : caractérisation des patients atteints de sclérose latérale amyotrophique évoluant depuis plus de 5 ans suivis au centre de référence de Bordeaux

  2014influential citation
• CHARACTERIZATION OF MOLECULAR ISOFORMS AND ROLE OF THE SURVIVAL MOTOR NEURON (SMN) IN MOTOR NEURONS DISEASES

  2014cites this paper
• The Genetics of Spinal Muscular Atrophy: Progress and Challenges

  2014cites this paper
• Ataxin-2 as potential disease modifier in C9ORF72 expansion carriers.

  2014influential citation
• Overexpression of survival motor neuron improves neuromuscular function and motor neuron survival in mutant SOD1 mice

  2014cites this paper
• CX 3 CR 1 Is a Modifying Gene of Survival and Progression in Amyotrophic Lateral Sclerosis

  2014cites this paper
• SMN1 duplications contribute to sporadic amyotrophic lateral sclerosis susceptibility: evidence from a meta-analysis.

  2014cites this paper
• The genetics and spread of Amyotrophic Lateral Sclerosis

  2014cites this paper
• Valproate Treatment in an ALS Patient Carrying a c.194G>A Spastin Mutation and SMN2 Homozygous Deletion

  2014cites this paper
• CX3CR1 Is a Modifying Gene of Survival and Progression in Amyotrophic Lateral Sclerosis

  2014cites this paper
• Therapeutic Potential of Mood Stabilizers Lithium and Valproic Acid: Beyond Bipolar Disorder

  2013cites this paper
• On the aetiology of ALS : a comprehensive genetic study

  2013cites this paper
• Spinal Muscular Atrophies

  2013cites this paper
• The Neuroprotective Drug Riluzole Acts via Small Conductance Ca2+-Activated K+ Channels to Ameliorate Defects in Spinal Muscular Atrophy Models

  2013influential citation
• Spinal muscular atrophy at the crossroads of basic science and therapy.

  2013cites this paper
• Spliceosome integrity is defective in the motor neuron diseases ALS and SMA

  2013cites this paper
• Study of Cyclophilin A Function in Models of Amyotrophic Lateral Sclerosis

  2013cites this paper
• Stress granules in neurodegeneration – lessons learnt from TAR DNA binding protein of 43 kDa and fused in sarcoma

  2013cites this paper
• The investigation of oxidative damage to nucleic acids during ageing and motor neuron disease

  2013cites this paper
• Protein SUMOylation, an emerging pathway in amyotrophic lateral sclerosis

  2013cites this paper
• Homozygous Survival Motor Neuron 2 Gene Deletion and Sporadic Lower Motor Neuron Disease in Children

  2013cites this paper
• SMN1 gene duplications are associated with sporadic ALS

  2012cites this paper
• Berberine activates Nrf2 nuclear translocation and protects against oxidative damage via a phosphatidylinositol 3-kinase/Akt-dependent mechanism in NSC34 motor neuron-like cells.

  2012cites this paper
• 12 – Maladies dégénératives du motoneurone

  2012cites this paper
• Amyotrophic lateral sclerosis: epidemiology, risk factors and treatment

  2012cites this paper
• Drug treatment for spinal muscular atrophy type I.

  2012cites this paper
• Complexity of familial amyotrophic lateral sclerosis

  2012cites this paper
• Homozygous SMN2 deletion is a protective factor in the Swedish ALS population

  2012cites this paper
• Mutant superoxide dismutase 1 (SOD1), a cause of amyotrophic lateral sclerosis, disrupts the recruitment of SMN, the spinal muscular atrophy protein to nuclear Cajal bodies.

  2012cites this paper
• Drug treatment for spinal muscular atrophy types II and III.

  2012cites this paper
• Genetics of Amyotrophic Lateral Sclerosis

  2012cites this paper
• Drug treatment for spinal muscular atrophy type I.

  2012cites this paper
• Drug treatment for spinal muscular atrophy types II and III.

  2011cites this paper
• Survival motor neuron (SMN) protein in the spinal anterior horn cells of patients with sporadic amyotrophic lateral sclerosis.

  2011cites this paper
• Homozygous SMN2 Deletion is a Major Risk Factor among Twenty-Five Korean Sporadic Amyotrophic Lateral Sclerosis Patients

  2011cites this paper
• Amyotrophic lateral sclerosis - looking for pathogenesis and effective therapy.

  2011cites this paper
• Leveraging health social networking communities in translational research

  2011cites this paper
• Drug treatment for spinal muscular atrophy type I.

  2011cites this paper
• Mutant Superoxide Dismutase-1-caused pathogenesis in Amyotrophic Lateral Sclerosis

  2010cites this paper
• Association between survivor motor neuron 2 (SMN2) gene homozygous deletion and sporadic lower motor neuron disease in a Korean population.

  2010cites this paper
• Skeletal muscle in motor neuron diseases: therapeutic target and delivery route for potential treatments.

  2010cites this paper
• Gene copy number variation and common human disease

  2010cites this paper
• Neuronal death in amyotrophic lateral sclerosis (ALS): what can we learn from genetics?

  2010cites this paper
• A HYBRID APPROACH FOR TRANSLATIONAL RESEARCH

  2010cites this paper
• RNA processing pathways in amyotrophic lateral sclerosis

  2010cites this paper
• Pathophysiology of neurodegeneration in familial amyotrophic lateral sclerosis.

  2009cites this paper
• Reduced expression of the Kinesin-Associated Protein 3 (KIFAP3) gene increases survival in sporadic amyotrophic lateral sclerosis

  2009cites this paper
• Identification of candidate genes for sporadic amyotrophic lateral sclerosis by array comparative genomic hybridization

  2009cites this paper
• Drug treatment for spinal muscular atrophy type I.

  2009cites this paper
• Genetic studies of amyotrophic lateral sclerosis: Controversies and perspectives

  2009cites this paper
• The importance of the SMN genes in the genetics of sporadic ALS

  2009cites this paper
• Prognostic factors in ALS: A critical review

  2009cites this paper
• Analysis of FGGY as a risk factor for sporadic amyotrophic lateral sclerosis

  2009cites this paper
• Physical activity as an exogenous risk factor in motor neuron disease (MND): A review of the evidence

  2009cites this paper
• The Genetics of Amyotrophic Lateral Sclerosis

  2009cites this paper
• Survival motor neuron deficiency enhances progression in an amyotrophic lateral sclerosis mouse model.

  2009cites this paper
• Randomized sequential trial of valproic acid in amyotrophic lateral sclerosis

  2009cites this paper
• Drug treatment for spinal muscular atrophy types II and III.

  2009cites this paper
• Cellular approach for the treatment of amyotrophic lateral sclerosis using adult mesenchymal stem cells

  2008cites this paper
• Inflammation in neurodegenerative disorders: friend or foe?

  2008cites this paper
• Copy-number variation in sporadic amyotrophic lateral sclerosis: a genome-wide screen.

  2008cites this paper
• Analysis of genome-wide copy number variation in Irish and Dutch ALS populations.

  2008cites this paper
• Chapter 4 Molecular mechanisms of motor neuron degeneration in amyotrophic lateral sclerosis.

  2007cites this paper
• Genetics of sporadic amyotrophic lateral sclerosis.

  2007cites this paper
• Investigation of the role of SMN1 and SMN2 haploinsufficiency as a risk factor for Hirayama's disease: clinical, neurophysiological and genetic characteristics in a Spanish series of 13 patients.

  2007cites this paper
• Chapter 19 Therapies in amyotrophic lateral sclerosis: Options for the near and far future.

  2007cites this paper
• Complex genetic approaches to neurodegenerative diseases.

  2007cites this paper
• Association of polymorphisms in vascular endothelial growth factor gene with the age of onset of amyotrophic lateral sclerosis

  2007cites this paper
• Molecular biology of amyotrophic lateral sclerosis: insights from genetics

  2006cites this paper
• Sporadic ALS is not associated with VAPB gene mutations in Southern Italy

  2006cites this paper
• VEGF C2578A polymorphism does not contribute to amyotrophic lateral sclerosis susceptibility in sporadic Chinese patients

  2006cites this paper
• SMN1 gene, but not SMN2, is a risk factor for sporadic ALS

  2006cites this paper
• Genetics of familial and sporadic amyotrophic lateral sclerosis.

  2006cites this paper
• The G93C mutation in superoxide dismutase 1: clinicopathologic phenotype and prognosis.

  2006cites this paper
• Amyotrophic lateral sclerosis as a complex genetic disease.

  2006cites this paper
• Spinal muscular atrophy: from gene to therapy.

  2006cites this paper
• Characterisation of the ovine model of McArdle's disease: development of therapeutic strategies

  2006cites this paper
• Mechanisms of Neuronal Death in a Transgenic Mouse Model for Amyotrophic Lateral Sclerosis

  2005cites this paper
• Superoxide dismutase 1 and amyotrophic lateral sclerosis

  2005cites this paper
• Neurodegenerative Diseases: Spinal muscular atrophies

  2005cites this paper
• Chapter 63 – Sporadic Motor Neuron Degeneration

  2005cites this paper
• Molecular and cellular pathways of neurodegeneration in motor neurone disease

  2005cites this paper